Page 15 - Multiple Sclerosis Ms News Today

A study of all MS patients in England taking a disease modifying therapy found higher infection and hospitalization rates in patients taking those drugs, even after COVID-19 vaccination.

TDP-43 protein, which is present in motor neurons in the brain and spinal cord of healthy individuals, was found in the dermis of patients with ALS.

Using molecular analysis to characterize immunologic response in patients with COVID-19.

Emotional or sexual abuse in childhood may increase risk for multiple sclerosis in women, and multiple kinds of abuse is tied to further risk, the first prospective study of its kind suggests.

Multiple sclerosis, sometimes thought of as primarily affecting White people, is also common and often more severe in Hispanic and Black people, a study assessing neighborhood-level data shows.

A test that measures kappa in cerebrospinal fluid is faster, easier, and less costly for diagnosing multiple sclerosis than a more commonly used test, new research suggests.

Prolonged consumption of antibiotic may have negative effects on cognition comparable to those caused by 3 to 4 years of aging.

In a randomized trial, depression improved compared to usual neurologist care.

B cell depletion can last well past the 6-month dosing regimen typically used with ocrelizumab or rituximab for multiple sclerosis or neuromyelitis optica spectrum disorders, new research suggests.

Consumption of a ketogenic diet is safe — and may help reduce disability and improve fatigue and depressive symptoms in patients with relapsing multiple sclerosis (MS), new research suggests.